GONAL-F

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Lithuania, Netherlands, New Zealand, Nigeria, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug GONAL-F contains one active pharmaceutical ingredient (API):

1	Follitropin alfa UNII 076WHW89TW - FOLLITROPIN
	In women, the most important effect resulting from parenteral administration of FSH is the development of mature Graafian follicles.
	Read more about Follitropin alfa

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03GA05	Follitropin alfa	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03G Gonadotropins and other ovulation stimulants → G03GA Gonadotropins
Discover more medicines within G03GA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	6431L, 6432M, 6433N, 8713N, 8714P, 8715Q
BR	Câmara de Regulação do Mercado de Medicamentos	525413010043803, 525413010043903, 525413010044003, 525421301152414
CA	Health Products and Food Branch	02248154, 02270382, 02270390, 02270404
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	26.611-09-05
EE	Ravimiamet	1035784, 1063886, 1107403, 1107414, 1173855, 1173866, 1207864, 1213513, 1217045, 1833993
ES	Centro de información online de medicamentos de la AEMPS	95001021, 95001025, 95001027, 95001033, 95001034, 95001035, 95001036
FI	Lääkealan turvallisuus- ja kehittämiskeskus	010102, 016892, 016927, 016938, 483844
FR	Base de données publique des médicaments	60749100, 62483399, 65329591, 65913137, 67112526
GB	Medicines & Healthcare Products Regulatory Agency	311260, 311262, 311266, 45254, 45258, 46344
HK	Department of Health Drug Office	41249, 49109, 51484, 53414, 53415, 53416
IE	Health Products Regulatory Authority	88465, 88468, 88469, 88470, 88471, 88485
IL	מִשְׂרַד הַבְּרִיאוּת	6542, 6543, 6544
LT	Valstybinė vaistų kontrolės tarnyba	1011802, 1012596, 1012597, 1012598, 1015881, 1028627, 1028628, 1028629, 1028633, 1089412
NG	Registered Drug Product Database	A6-0410, A6-0411, A6-0412
Switch country to Nigeria in order to find specific presentations of GONAL-F
NL	Z-Index G-Standaard	14805200, 14806746, 14808447, 15008355, 15008371, 15092399
NL	Z-Index G-Standaard, PRK	117528, 117536, 117544, 67458, 67466, 67474
NZ	Medicines and Medical Devices Safety Authority	10779, 10780, 10781, 11567, 8497, 9908
PL	Rejestru Produktów Leczniczych	100091488, 100126809, 100126815, 100126821, 100126838, 100126844, 100126850, 100448424
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65133001, W65133002, W65133003, W65133004, W65134001, W65134002, W65135001, W65135002, W65136001, W65136002
SG	Health Sciences Authority	11779P, 12450P, 13022P, 13023P, 13024P
TN	Direction de la Pharmacie et du Médicament	22073011, 22073012, 22073013, 4703011, 4703012, 4703031
TR	İlaç ve Tıbbi Cihaz Kurumu	8699777790119, 8699777790126, 8699777790133, 8699777790140, 8699777790157, 8699777950278, 8699777950285, 8699777950292
US	FDA, National Drug Code	44087-1115, 44087-1116, 44087-1117
ZA	Health Products Regulatory Authority	33/21.10/0522, 36/21.10/0307